Iribarren ME, et al. Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma. P2520. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Behandeling stadium II-III niet-kleincellig longcarcinoom gaat flink op de schop
apr 2024 | Immuuntherapie, Longoncologie